Companion Animal Welfare

Dog Welfare and Chronic Skin Management

Chronic skin disease including atopic dermatitis requires long-term management commitment. New biological treatments have transformed outcomes for many dogs with this common welfare problem.

Key Facts

Atopic dermatitis affects around 10% of dogs and causes chronic pruritus and skin infection
Oclacitinib (Apoquel) and lokivetmab (Cytopoint) have transformed management of canine AD
Allergen-specific immunotherapy provides long-term disease modification for suitable candidates
Secondary bacterial and yeast infections require targeted treatment alongside immunotherapy
Environmental management including dust mite reduction helps many dogs with environmental allergens

Welfare Considerations

Chronic atopic dermatitis causes persistent suffering that modern treatments can now substantially reduce. Access to appropriate specialist dermatology assessment and modern biologics transforms welfare for affected dogs.

What You Can Do

Seek specialist dermatology assessment for dogs with recurrent skin disease
Discuss modern treatment options including Apoquel and Cytopoint with your vet
Consider allergen testing and immunotherapy for long-term disease modification
Manage secondary infections promptly to reduce the welfare burden